Telomerase activation induces elongation of the telomeric single-stranded overhang, but does not prevent chromosome aberrations in human vascular endothelial cells

Biochemical and Biophysical Research Communications

Volumn 353, Issue 4, 2007, Pages 926-932

  Anno, Kumiko ^a   Hayashi, Akane ^a   Takahashi, Tomoko ^b   Mitsui, Youji ^b   Ide, Toshinori ^c   Tahara, Hidetoshi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^c HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

3 Telomeric overhang; Chromosome; Endothelial cells; G tail; Immortalization; Telomerase; Telomere; Telomere binding protein; TERT

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE; VON WILLEBRAND FACTOR;

ARTICLE; CELL STRUCTURE; CELL TRANSFORMATION; CHROMOSOME 13; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CHROMOSOME SIZE; CHROMOSOME STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE; TELOMERE G TAIL; UMBILICAL VEIN; UPREGULATION; VASCULAR ENDOTHELIUM;

BLOTTING, WESTERN; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DNA, SINGLE-STRANDED; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC VECTORS; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MICROSCOPY, FLUORESCENCE; RNA, MESSENGER; TELOMERASE; TELOMERE; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 33846125928     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.112     Document Type: Article

References (20)

1. de Lange T. Protection of mammalian telomeres. Oncogene 21 (2002) 532-540
2. de Lange T. T-loops and the origin of telomeres. Nat. Rev. Mol. Cell Biol. 5 (2004) 323-329
3. Makarov V.L., Hirose Y., and Langmore J.P. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88 (1997) 657-666
4. Harley C.B. Telomere loss: mitotic clock or genetic time bomb?. Mutat. Res. 256 (1991) 271-282
5. Granger M.P., Wright W.E., and Shay J.W. Telomerase in cancer and aging. Crit. Rev. Oncol. Hematol. 41 (2002) 29-40
6. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
7. Carney S.A., Tahara H., Swartz C.D., Risinger J.I., He H., Moore A.B., Haseman J.K., Barrett J.C., and Dixon D. Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab. Invest. 82 (2002) 719-728
8. Stewart S.A., Ben-Porath I., Carey V.J., O'Connor B.F., Hahn W.C., and Weinberg R.A. Erosion of the telomeric single-strand overhang at replicative senescence. Nat. Genet. 33 (2003) 492-496
9. Chai W., Shay J.W., and Wright W.E. Human telomeres maintain their overhang length at senescence. Mol. Cell Biol. 25 (2005) 2158-2168
10. Tahara H., Kusunoki M., Yamanaka Y., Matsumura S., and Ide T. G-tail telomere HPA: simple measurement of human single-stranded telomeric overhangs. Nat. Methods 2 (2005) 829-831
11. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 27 (2002) 339-344
12. Parrinello S., Samper E., Krtolica A., Goldstein J., Melov S., and Campisi J. Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat. Cell Biol. 5 (2003) 741-747
13. Zhang L., Aviv H., Gardner J.P., Okuda K., Patel S., Kimura M., Bardeguez A., and Aviv A. Loss of chromosome 13 in cultured human vascular endothelial cells. Exp. Cell Res. 260 (2000) 357-364
14. Minamino T., Miyauchi H., Yoshida T., Tateno K., Kunieda T., and Komuro I. Vascular cell senescence and vascular aging. J. Mol. Cell Cardiol. 36 (2004) 175-183
15. Lei M., Podell E.R., and Cech T.R. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat. Struct. Mol. Biol. 11 (2004) 1223-1229
16. van Steensel B., Smogorzewska A., and de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 92 (1998) 401-413
17. Tahara H., Shin-Ya K., Seimiya H., Yamada H., Tsuruo T., and Ide T. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells. Oncogene 25 (2006) 1955-1966
18. Wu L., Multani A.S., He H., Cosme-Blanco W., Deng Y., Deng J.M., Bachilo O., Pathak S., Tahara H., Bailey S.M., Deng Y., Behringer R.R., and Chang S. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126 (2006) 49-62
19. He H., Multani A.S., Cosme-Blanco W., Tahara H., Ma J., Deng Y., Deng J.M., Bachilo O., Pathak S., Deng Y., and Chang S. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO 25 (2006) 5180-5190
20. Hirose M., AbeHashimoto J., Ogura K., Tahara H., Ide T., and Yoshimura T. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J. Cancer Res. Clin. Oncol. 123 (1997) 337-344